Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

1.

Comparative Outcome of Computed Tomography-guided Percutaneous Radiofrequency Ablation, Partial Nephrectomy or Radical Nephrectomy in the Treatment of Stage T1 Renal Cell Carcinoma.

Cooper CJ, Teleb M, Dwivedi A, Rangel G, Sanchez LA, Laks S, Akle N, Nahleh Z.

Rare Tumors. 2015 Mar 16;7(1):5583. doi: 10.4081/rt.2015.5583. eCollection 2015 Feb 11.

2.

Recurrence and metastasis of breast cancer is influenced by ovarian hormone's effect on breast cancer stem cells.

Nandy SB, Gangwani L, Nahleh Z, Subramani R, Arumugam A, de la Rosa JM, Lakshmanaswamy R.

Future Oncol. 2015 Mar;11(6):983-95. doi: 10.2217/fon.14.301.

PMID:
25760978
3.

Clinical and pathological characteristics of Hispanic BRCA-associated breast cancers in the American-Mexican border city of El Paso, TX.

Nahleh Z, Otoukesh S, Dwivedi AK, Mallawaarachchi I, Sanchez L, Saldivar JS, Cataneda K, Heydarian R.

Am J Cancer Res. 2014 Dec 15;5(1):466-71. eCollection 2015.

4.

Multicentric Castleman's Disease and Kaposi's Sarcoma in a HIV-Positive Patient on Highly Active Antiretroviral Therapy.

Ortega L, Cooper CJ, Otoukesh S, Mojtahedzadeh M, Didia CS, Torabi A, Nahleh Z.

Rare Tumors. 2014 Aug 6;6(3):5480. doi: 10.4081/rt.2014.5480. eCollection 2014 Jul 30.

5.

Acute leukemia of ambiguous lineage with trisomy 4 as the sole cytogenetic abnormality: A case report and literature review.

Moraveji S, Torabi A, Nahleh Z, Farrag S, Gaur S.

Leuk Res Rep. 2014 May 2;3(2):33-5. doi: 10.1016/j.lrr.2014.04.003. eCollection 2014.

6.

Combination chemotherapy regimen in a patient with metastatic malignant pheochromocytoma and neurofibromatosis type 1.

Otoukesh S, Cooper CJ, Lou W, Mojtahedzadeh M, Nasrazadani A, Wampler M, Nahleh Z.

Am J Case Rep. 2014 Mar 25;15:123-7. doi: 10.12659/AJCR.890181. eCollection 2014.

7.

Paraneoplastic limbic encephalitis, an uncommon presentation of a common cancer: Case report and discussion.

Said S, Cooper CJ, Reyna E, Alkhateeb H, Diaz J, Nahleh Z.

Am J Case Rep. 2013 Oct 1;14:391-4. doi: 10.12659/AJCR.889560. eCollection 2013.

8.

Changing frequency of equivocal HER-2/neu scores and factors predictive of negative HER 2/neu fluorescent in situ hybridisation in invasive carcinomas of the breast.

Boulos F, Farra CG, Saad Aldin EM, Masaad C, Hassoun Y, Fedda F, Doumiati H, Tawil AN, Nasser Z, Nahleh Z, Tfayli A.

J Clin Pathol. 2014 Mar;67(3):204-9. doi: 10.1136/jclinpath-2013-201546. Epub 2013 Oct 9.

PMID:
24108431
9.

Breast metastases from an adrenocorticotropic hormone secreting thymic neuro-endocrine tumor.

Gaur S, Ayyappan AP, Nahleh Z.

Breast Dis. 2013 Jan 1;34(2):81-6. doi: 10.3233/BD-130354. Review.

PMID:
23948804
10.

Perceptions and needs of women with metastatic breast cancer: a focus on clinical trials.

Nahleh ZA, Lin NU, Wolff AC, Cardoso F; BIG-NABCG collaboration.

Breast. 2013 Jun;22(3):370-3. doi: 10.1016/j.breast.2013.02.017. Epub 2013 Mar 25.

11.

Physical symptom profile for adult cancer inpatients at a Lebanese cancer unit.

Halawi R, Aldin ES, Baydoun A, Dbouk H, Nahleh Z, Nasser Z, Tfayli A.

Eur J Intern Med. 2012 Dec;23(8):e185-9. doi: 10.1016/j.ejim.2012.08.018. Epub 2012 Sep 23.

PMID:
23009863
12.

A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints.

Fumagalli D, Bedard PL, Nahleh Z, Michiels S, Sotiriou C, Loi S, Sparano JA, Ellis M, Hylton N, Zujewski JA, Hudis C, Esserman L, Piccart M; BIG-NABCG collaboration.

Lancet Oncol. 2012 Jun;13(6):e240-8. doi: 10.1016/S1470-2045(11)70378-3.

PMID:
22652232
13.

Heat shock proteins in cancer: targeting the 'chaperones'.

Nahleh Z, Tfayli A, Najm A, El Sayed A, Nahle Z.

Future Med Chem. 2012 May;4(7):927-35. doi: 10.4155/fmc.12.50. Review.

PMID:
22571616
14.

Tryptophan metabolism in breast cancers: molecular imaging and immunohistochemistry studies.

Juhász C, Nahleh Z, Zitron I, Chugani DC, Janabi MZ, Bandyopadhyay S, Ali-Fehmi R, Mangner TJ, Chakraborty PK, Mittal S, Muzik O.

Nucl Med Biol. 2012 Oct;39(7):926-32. doi: 10.1016/j.nucmedbio.2012.01.010. Epub 2012 Mar 22.

15.

Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer.

Hussein YR, Sood AK, Bandyopadhyay S, Albashiti B, Semaan A, Nahleh Z, Roh J, Han HD, Lopez-Berestein G, Ali-Fehmi R.

Hum Pathol. 2012 Oct;43(10):1638-44. doi: 10.1016/j.humpath.2011.12.004. Epub 2012 Mar 19.

16.

Glut-1 Expression Correlates with Basal-like Breast Cancer.

Hussein YR, Bandyopadhyay S, Semaan A, Ahmed Q, Albashiti B, Jazaerly T, Nahleh Z, Ali-Fehmi R.

Transl Oncol. 2011 Dec;4(6):321-7. Epub 2011 Dec 1.

17.

Rhodococcus equi venous catheter infection: a case report and review of the literature.

Guerrero R, Bhargava A, Nahleh Z.

J Med Case Rep. 2011 Aug 9;5:358. doi: 10.1186/1752-1947-5-358.

18.

Molecular markers of epithelial-to-mesenchymal transition are associated with tumor aggressiveness in breast carcinoma.

Sethi S, Sarkar FH, Ahmed Q, Bandyopadhyay S, Nahleh ZA, Semaan A, Sakr W, Munkarah A, Ali-Fehmi R.

Transl Oncol. 2011 Aug;4(4):222-6. Epub 2011 Aug 1.

19.

Breast cancer, obesity and hormonal imbalance: a worrisome trend.

Nahleh Z.

Expert Rev Anticancer Ther. 2011 Jun;11(6):817-9. doi: 10.1586/era.11.67. No abstract available.

PMID:
21707275
20.

How to reduce your cancer risk: mechanisms and myths.

Nahleh Z, Bhatti NS, Mal M.

Int J Gen Med. 2011 Apr 8;4:277-87. doi: 10.2147/IJGM.S18657.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk